ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
164 hedge funds and large institutions have $181M invested in Antares Pharma, Inc. in 2020 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 39 increasing their positions, 56 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
30% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 56
60% less call options, than puts
Call options by funds: $345K | Put options by funds: $865K
Holders
164
Holding in Top 10
4
Calls
$345K
Puts
$865K
Top Buyers
| 1 | +$3.25M | |
| 2 | +$1.5M | |
| 3 | +$1.22M | |
| 4 |
AC
Armistice Capital
New York
|
+$1.16M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$976K |
Top Sellers
| 1 | -$9.89M | |
| 2 | -$1.76M | |
| 3 | -$1.39M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.09M |
| 5 |
Two Sigma Advisers
New York
|
-$873K |